These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Low-toxicity transferrin-guided polymersomal doxorubicin for potent chemotherapy of orthotopic hepatocellular carcinoma in vivo. Wei Y, Gu X, Cheng L, Meng F, Storm G, Zhong Z. Acta Biomater; 2019 Jul 01; 92():196-204. PubMed ID: 31102765 [Abstract] [Full Text] [Related]
3. GE11-Directed Functional Polymersomal Doxorubicin as an Advanced Alternative to Clinical Liposomal Formulation for Ovarian Cancer Treatment. Zou Y, Xia Y, Meng F, Zhang J, Zhong Z. Mol Pharm; 2018 Sep 04; 15(9):3664-3671. PubMed ID: 29570299 [Abstract] [Full Text] [Related]
4. Robust, tumor-homing and redox-sensitive polymersomal doxorubicin: A superior alternative to Doxil and Caelyx? Zou Y, Meng F, Deng C, Zhong Z. J Control Release; 2016 Oct 10; 239():149-58. PubMed ID: 27569664 [Abstract] [Full Text] [Related]
5. Targeted glioma chemotherapy by cyclic RGD peptide-functionalized reversibly core-crosslinked multifunctional poly(ethylene glycol)-b-poly(ε-caprolactone) micelles. Fang Y, Jiang Y, Zou Y, Meng F, Zhang J, Deng C, Sun H, Zhong Z. Acta Biomater; 2017 Mar 01; 50():396-406. PubMed ID: 28065871 [Abstract] [Full Text] [Related]
7. Doxorubicin Delivered via ApoE-Directed Reduction-Sensitive Polymersomes Potently Inhibit Orthotopic Human Glioblastoma Xenografts in Nude Mice. Ouyang J, Jiang Y, Deng C, Zhong Z, Lan Q. Int J Nanomedicine; 2021 Mar 01; 16():4105-4115. PubMed ID: 34163162 [Abstract] [Full Text] [Related]
10. Self-crosslinkable and intracellularly decrosslinkable biodegradable micellar nanoparticles: A robust, simple and multifunctional nanoplatform for high-efficiency targeted cancer chemotherapy. Zou Y, Fang Y, Meng H, Meng F, Deng C, Zhang J, Zhong Z. J Control Release; 2016 Dec 28; 244(Pt B):326-335. PubMed ID: 27245309 [Abstract] [Full Text] [Related]
16. cRGD-decorated biodegradable polytyrosine nanoparticles for robust encapsulation and targeted delivery of doxorubicin to colorectal cancer in vivo. Gu X, Wei Y, Fan Q, Sun H, Cheng R, Zhong Z, Deng C. J Control Release; 2019 May 10; 301():110-118. PubMed ID: 30898610 [Abstract] [Full Text] [Related]
17. Lung cancer specific and reduction-responsive chimaeric polymersomes for highly efficient loading of pemetrexed and targeted suppression of lung tumor in vivo. Yang W, Yang L, Xia Y, Cheng L, Zhang J, Meng F, Yuan J, Zhong Z. Acta Biomater; 2018 Apr 01; 70():177-185. PubMed ID: 29410335 [Abstract] [Full Text] [Related]
19. Selective targeted delivery of doxorubicin via conjugating to anti-CD24 antibody results in enhanced antitumor potency for hepatocellular carcinoma both in vitro and in vivo. Ma Z, He H, Sun F, Xu Y, Huang X, Ma Y, Zhao H, Wang Y, Wang M, Zhang J. J Cancer Res Clin Oncol; 2017 Oct 01; 143(10):1929-1940. PubMed ID: 28536738 [Abstract] [Full Text] [Related]
20. In vivo pharmacokinetics, biodistribution and the anti-tumor effect of cyclic RGD-modified doxorubicin-loaded polymers in tumor-bearing mice. Wang C, Li Y, Chen B, Zou M. Colloids Surf B Biointerfaces; 2016 Oct 01; 146():31-8. PubMed ID: 27244048 [Abstract] [Full Text] [Related] Page: [Next] [New Search]